"Auckland Eye is New Zealand's centre of excellence for eye care. Combined with Oasis Surgical, Auckland's premier eye surgery facility, we offer superior treatment and world-class care in a relaxed, friendly environment. Our team of leading experts provide assessment and management of a comprehensive range of eye conditions including SMILE and LASIK laser vision correction, cataract surgery, glaucoma treatment, eyelid surgery and pediatrics."

During the past decade, Auckland Eye conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Auckland Eye" #1 sponsor was "AcuFocus, Inc." with 2 trials, followed by "Allergan" with 1 trials sponsored, "Apellis Pharmaceuticals, Inc." with 1 trials sponsored, "Clearside Biomedical, Inc." with 1 trials sponsored and "Ionis Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Auckland Eye" #1 collaborator was "Novotech (Australia) Pty Limited" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Auckland Eye" are "Geographic Atrophy" (2 trials), "Presbyopia" (2 trials), "Age Related Macular Degeneration" (1 trials), "Diabetic Macular Oedema" (1 trials) and "Macular Degeneration" (1 trials). Many other conditions were trialed in "Auckland Eye" in a lesser frequency.

Most popular intervention types in "Auckland Eye" are "Drug" (5 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (2 trials), "Abicipar Pegol" (1 trials), "AcuFocus Corneal Inlay" (1 trials), "AcuFocus Corneal Inlay ACI 7000PDT" (1 trials) and "IBE-814 140ug" (1 trials). Other intervention names were less common.

The vast majority of trials in "Auckland Eye" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Auckland Eye". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Auckland Eye, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Auckland Eye, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".